Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes

Alain Lescoat, Susan L Murphy, David Roofeh, John D Pauling, Michael Hughes, Robert Sandler, François Zimmermann, Rachel Wessel, Whitney Townsend, Lorinda Chung, Christopher P Denton, Peter A Merkel, Virginia Steen, Yannick Allanore, Francesco Del Galdo, Dominique Godard, David Cella, Sue Farrington, Maya H Buch, Dinesh Khanna

Open source

DOI: 10.1177/2397198320961967
Published: 2020-10-05
Container: Journal of Scleroderma and Related Disorders
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/2397198320961967,
  title = {Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes},
  author = {Alain Lescoat and Susan L Murphy and David Roofeh and John D Pauling and Michael Hughes and Robert Sandler and François Zimmermann and Rachel Wessel and Whitney Townsend and Lorinda Chung and Christopher P Denton and Peter A Merkel and Virginia Steen and Yannick Allanore and Francesco Del Galdo and Dominique Godard and David Cella and Sue Farrington and Maya H Buch and Dinesh Khanna},
  year = {2020},
  journal = {Journal of Scleroderma and Related Disorders},
  doi = {10.1177/2397198320961967},
  url = {https://doi.org/10.1177/2397198320961967}
}

RIS

TY  - JOUR
TI  - Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes
AU  - Alain Lescoat
AU  - Susan L Murphy
AU  - David Roofeh
AU  - John D Pauling
AU  - Michael Hughes
AU  - Robert Sandler
AU  - François Zimmermann
AU  - Rachel Wessel
AU  - Whitney Townsend
AU  - Lorinda Chung
AU  - Christopher P Denton
AU  - Peter A Merkel
AU  - Virginia Steen
AU  - Yannick Allanore
AU  - Francesco Del Galdo
AU  - Dominique Godard
AU  - David Cella
AU  - Sue Farrington
AU  - Maya H Buch
AU  - Dinesh Khanna
PY  - 2020
JO  - Journal of Scleroderma and Related Disorders
DO  - 10.1177/2397198320961967
UR  - https://doi.org/10.1177/2397198320961967
ER  -

APA

Lescoat, A., Murphy, S. L., Roofeh, D., Pauling, J. D., Hughes, M., Sandler, R., Zimmermann, F., Wessel, R., Townsend, W., Chung, L., Denton, C. P., Merkel, P. A., Steen, V., Allanore, Y., Galdo, F. D., Godard, D., Cella, D., Farrington, S., Buch, M. H., & Khanna, D. (2020). Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. Journal of Scleroderma and Related Disorders. https://doi.org/10.1177/2397198320961967

Source records

crossref · retrieved 2026-09-26T04:53:35.228Z